Amgen, US0311621009

Amgen stock was last quoted after the close

Published on 09/23/2026 at 22:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

After the close on September 23, 2026, Amgen stock last traded at USD 405.18 on Cboe BZX at 6:29 p.m. ET, after a 4.34 percent gain on September 22.

Fotorealistische moderne Biotech-Produktionsanlage mit Glasfassade, Bioreaktoren und Palmen unter blauem Himmel
Amgen Inc. (ISIN US0311621009) zeigt fotorealistisch eine moderne Biotech-Anlage mit Bioreaktoren in Kalifornien, Illustration mit AI erstellt.

After the close on September 23, 2026, Amgen stock was last quoted at USD 405.18 on Cboe BZX at 6:29 p.m. ET. The latest substantiated regular-session close was USD 410.24 on the Nasdaq on September 22, 2026, up 4.34 percent from the prior close.

September 22, 2026 session figures

Amgen Inc. (ISIN US0311621009, Nasdaq: AMGN) opened at USD 410.24 on September 23, 2026, while the reported intraday range ran from USD 398.61 to USD 412.73 and volume reached 166,000 shares. The latest quoted level of USD 405.18 was USD 5.06 below the September 22 close.

The September 22 advance followed positive Phase 3 results for dazodalibep in Sjogren's disease, according to AD HOC NEWS. The Nasdaq Composite closed 0.45 percent higher on September 22, providing a broader market comparison.

After-hours trading on September 23, 2026

Jefferies maintained a Hold rating on September 23 and raised its target to USD 410 from USD 367, according to Investing.com. The extended U.S. session runs until 8:00 p.m. ET, and the next U.S. trading session follows on September 24, 2026.

Disclaimer...

en | US0311621009 | AMGEN | boerse | 70170387 | bgmi